Finalist
3-in-1: A winning combination for Sevikar HCT
Summary of work
Despite 8.5 million people in the UK living with high blood pressure, the topic secures limited media attention, and new product launches are a thing of the past.
Against a backdrop of unprecedented barriers to entry, the agency launched the first three-in-one combination pill for the treatment of hypertension and delivered a flawless campaign that resulted in extensive national, broadcast, trade, consumer and online coverage.
Judges’ comments
This was a really creative hardworking media launch with good outcomes – in particular with stakeholders. In a challenging market the team managed to connect with a hard to reach audience. As a result they achieved more than just great coverage – this campaign is enduring.
Testimonials and Judges’ comments
European communications director: The campaign resulted in the best media coverage Daiichi Sankyo Europe has ever achieved. The extent of the coverage has had an enormously positive impact on overall awareness of Sevikar HCT and Daiichi Sankyo’s cardiovascular portfolio. In addition, with news of the campaign reaching Tokyo, the campaign has highlighted the importance of investment in product communications and has resulted in a commitment to invest more in PR.
